Abiopharma

Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company

HealthEquity to Enhance Member Experience with Agentic AI

Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission

AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London

Jaguar Health Provides Recap of November 8, 2025 Presentation on Groundbreaking Results of Proof-of-Concept Study of Crofelemer for Treatment of Pediatric Intestinal Failure at NASPGHAN Annual Meeting

Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results

Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger

Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented

HCA Healthcare - HCA Healthcare Surpasses 100,000 Pounds of Collected Medication in Year Seven of Annual“Crush the Crisis”